| Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production H Cao, M Sekiya, ME Ertunc, MF Burak, JR Mayers, A White, K Inouye, ... Cell metabolism 17 (5), 768-778, 2013 | 260 | 2013 |
| Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis J Pihlajamäki, C Lerin, P Itkonen, T Boes, T Floss, J Schroeder, F Dearie, ... Cell metabolism 14 (2), 208-218, 2011 | 165 | 2011 |
| Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes MF Burak, KE Inouye, A White, A Lee, G Tuncman, ES Calay, M Sekiya, ... Science translational medicine 7 (319), 319ra205-319ra205, 2015 | 94 | 2015 |
| Insights From a Short-Term Protein-Calorie Restriction Exploratory Trial in Elective Carotid Endarterectomy Patients. OCK Kip P, Trocha KM, Tao M, O'leary JJ, Ruske J, Giulietti JM, Trevino ... Vasc Endovascular Surgery, 470-476, 2019 | 13* | 2019 |
| Metabolic changes in androgen-deprived nondiabetic men with prostate cancer are not mediated by cytokines or aP2 T Gagliano-Jucá, MF Burak, KM Pencina, Z Li, RR Edwards, TG Travison, ... The Journal of Clinical Endocrinology & Metabolism 103 (10), 3900-3908, 2018 | 13 | 2018 |
| Short-term pre-operative protein caloric restriction in elective vascular surgery patients: a randomized clinical trial P Kip, TJ Sluiter, JK Moore, A Hart, J Ruske, J O’Leary, J Jung, M Tao, ... Nutrients 13 (11), 4024, 2021 | 7 | 2021 |
| Response to Brosch et al. J Pihlajamäki, C Lerin, D Kaminska, S Venesmaa, P Itkonen, T Boes, ... Cell metabolism 15 (3), 267-269, 2012 | 3 | 2012 |
| Anti-aP2 antibodies and antigen binding agents to treat metabolic disorders GS Hotamisligil, MF Burak, F Engin, SB Widenmaier, EH Roberts, ... US Patent 10,160,798, 2018 | 2 | 2018 |
| Endothelial-derived FABP4 constitutes the majority of basal circulating hormone and regulates lipolysis-driven insulin secretion KE Inouye, KJ Prentice, A Lee, ZB Wang, C Dominguez-Gonzalez, ... JCI insight 8 (14), 2023 | 1 | 2023 |
| Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders GS Hotamisligil, MF Burak, F Engin, SB Widenmaier, EH Roberts, ... US Patent 11,014,979, 2021 | 1 | 2021 |
| OR01-1 Leveraging Immunometabolic Control to Prevent and Treat Obesity Related Asthma MF Burak, N Dagtekin, P Bejo, E Vaillancourt, L Liu, C Gorgun, E Rimm, ... Journal of the Endocrine Society 3 (Supplement_1), OR01-1, 2019 | 1 | 2019 |
| From Fundamentals to the Clinic: Advancing Obesity Research in Endocrinology Z Madak-Erdogan, SR Hammes, MF Burak Journal of the Endocrine Society 8 (6), bvae066, 2024 | | 2024 |
| Protocol for a randomized placebo-controlled clinical trial using pure palmitoleic acid to ameliorate insulin resistance and lipogenesis in overweight and obese subjects with … E Cetin, B Pedersen, LM Porter, GK Adler, MF Burak Frontiers in Endocrinology 14, 1306528, 2024 | | 2024 |
| FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection (preprint) H Baazim, E Koyuncu, G Tuncman, MF Burak, L Merkel, N Bahour, ... | | 2024 |
| FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection H Baazim, E Koyuncu, G Tuncman, MF Burak, L Merkel, N Bahour, ... bioRxiv, 2024.02. 10.579717, 2024 | | 2024 |
| Anti-ap2 antibodies and antigen binding agents to treat metabolic disorders GS Hotamisligil, MF Burak, F Engin, SB Widenmaier, K Inouye, ... US Patent App. 17/327,170, 2022 | | 2022 |
| Abstract# 787708: Identification of FABP4 (AP2) as an Adipo-Pulmonary Regulator of Airway Function in Obesity Related Asthma M Burak Endocrine Practice 26, 169-170, 2020 | | 2020 |
| Anticuerpos anti-ap2 y agentes antiaglutinantes para el tratamiento de desordenes metabolicos KL Tyson, GS Hotamisligil, MF Burak, F Engin, SB Widenmaier, ... | | 2018 |
| Anticuerpos anti-proteína de unión al lípido de adipocito humana (ap2) y agentes de unión al antígeno F Engin, CB Doyle, KJ Madeleine, KL Tyson, E Helen, AR Moore, ... | | 2018 |
| DEVELOPMENT OF AN ANTI-AP2 MONOCLONAL ANTIBODY TO TREAT OBESITY RELATED DIABETES AND FATTY LIVER DISEASE M Burak, A White, MD Gokhan Hotamisligil Endocrine Practice 24, 41-41, 2018 | | 2018 |
